|
| 37633258 | Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023. | Clin Infect Dis | 2024 |
| 36031405 | Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial. | Clin Infect Dis | 2023 |
| 37479609 | Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. | Vaccine | 2023 |
| 37305842 | Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020. | Open Forum Infect Dis | 2023 |
| 37333688 | Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study. | Lancet Reg Health Am | 2023 |
| 37026401 | Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. | Pediatrics | 2023 |
| 36921274 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36694363 | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study. | Clin Infect Dis | 2023 |
| 36920396 | Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. | JAMA Netw Open | 2023 |
| 36611252 | Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness. | Clin Infect Dis | 2023 |
| 36806690 | Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance. | J Infect Dis | 2023 |
| 34320171 | Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). | Clin Infect Dis | 2022 |
| 35710506 | Vaccine-associated attenuation of subjective severity among outpatients with influenza. | Vaccine | 2022 |
| 35862287 | Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35415884 | Consistency of self-reported and documented historical influenza vaccination status of US healthcare workers. | Influenza Other Respir Viruses | 2022 |
| 36580430 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36264840 | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36379754 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. | Vaccine | 2022 |
| 36191948 | Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. | BMJ | 2022 |
| 36156146 | Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. | JAMA Netw Open | 2022 |
| 35239634 | Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35176007 | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085224 | Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34967121 | Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. | Am J Transplant | 2022 |
| 35023288 | Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021. | Influenza Other Respir Viruses | 2022 |
| 32006430 | Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017. | Clin Infect Dis | 2021 |
| 33726743 | Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. | BMC Public Health | 2021 |
| 34735426 | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34735425 | Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34245243 | Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. | Clin Infect Dis | 2021 |
| 33956782 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged â¿¥65 Years - United States, January-March 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 32800465 | Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. | Vaccine | 2020 |
| 30408341 | Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011-12-2015-16. | Influenza Other Respir Viruses | 2019 |
| 30204854 | Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season. | Clin Infect Dis | 2019 |
| 30371753 | Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. | Clin Infect Dis | 2019 |
| 29249545 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. | Vaccine | 2018 |
| 30420119 | Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. | Vaccine | 2018 |
| 30646067 | Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons. | JAMA Netw Open | 2018 |
| 29447141 | Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. | MMWR Morb Mortal Wkly Rep | 2018 |
| 29361005 | Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. | J Infect Dis | 2018 |
| 29402578 | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. | Vaccine | 2018 |
| 28792867 | Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. | N Engl J Med | 2017 |
| 28408121 | Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season. | Vaccine | 2017 |
| 28207689 | Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. | MMWR Morb Mortal Wkly Rep | 2017 |
| 26738884 | Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. | Pediatrics | 2016 |
| 26334765 | Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. | J Med Virol | 2016 |
| 26658375 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses. | Pediatr Infect Dis J | 2016 |
| 27702768 | 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. | Clin Infect Dis | 2016 |
| 26743842 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. | J Infect Dis | 2016 |
| 25406334 | Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. | J Infect Dis | 2015 |